GlassScriptPhysician profile
Kevin Morgan
NPI 1689173031
$31,750.17
in general payments reported to CMS, 2019-2025
27 companies · $4,816 in 2025
The $4,816 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $186 · 2022: $434 · 2023: $26K · 2024: $307 · 2025: $4,816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Education: $3,000 · Food and Beverage: $2,488 · Travel and Lodging: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Education | $3,000.00 |
| Food and Beverage | $2,488.26 |
| Travel and Lodging | $641.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,785.07 | 2021-2025 | Lithovue, General - Therapies, Rezum Generator |
| Intuitive Surgical, INC. | $3,742.90 | 2023-2025 | |
| Procept Biorobotics Corporation | $599.29 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Cook Medical LLC | $268.56 | 2023 | Resonance, Fiber Dust, S~Curve |
| Medtronic, INC. | $229.60 | 2022-2024 | Interstim |
| Dornier Medtech America, INC | $163.52 | 2025 | Dornier Medtech |
| Valencia Technologies Corporation | $155.19 | 2025 | Ecoin Device Kit |
| Astellas Pharma US INC | $99.30 | 2023 | Xtandi |
| Profound Medical Corp. | $79.71 | 2025 | Tulsa-Pro |
| Sumitomo Pharma America, INC. | $79.52 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $58.61 | 2023-2025 | Eligard |
| Endo Pharmaceuticals INC. | $56.32 | 2021-2023 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $49.87 | 2022 | |
| Immunitybio, INC. | $38.33 | 2025 | |
| Calyxo, INC. | $37.93 | 2025 | Cvac Aspiration System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $34.58 | 2023-2025 | Jelmyto |
| Blue Earth Diagnostics | $31.26 | 2025 | Posluma |
| Olympus America INC. | $31.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.93 | 2025 | |
| Innovation Technologies INC | $29.37 | 2023 | Irrisept |
| Novartis Pharmaceuticals Corporation | $29.28 | 2025 | |
| Pfizer INC. | $25.82 | 2021 | |
| Photocure INC | $23.48 | 2025 | Cysview |
| Angiodynamics, INC. | $18.20 | 2025 | Nanoknife |
| Agiliti Surgical, INC. | $17.90 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Hollister Incorporated | $17.68 | 2023 | Infyna Chic |
| Kci USA, INC. | $16.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.